1. Bao, Yi, Zhai, Jianning, Chen, Huarong, To, Ka Fai, Yu, Jun. 2023. Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. In Gut, 72, 1497-1509. doi:10.1136/gutjnl-2022-328845. https://pubmed.ncbi.nlm.nih.gov/36717220/
2. Liu, Tao, Wei, Qinglv, Jin, Jing, Zou, Dongling, Yi, Ping. . The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. In Nucleic acids research, 48, 3816-3831. doi:10.1093/nar/gkaa048. https://pubmed.ncbi.nlm.nih.gov/31996915/
3. Wang, Shiyan, Gao, Shanshan, Zeng, Yong, Yu, Jun, He, Housheng Hansen. 2021. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer. In Gastroenterology, 162, 1183-1196. doi:10.1053/j.gastro.2021.12.269. https://pubmed.ncbi.nlm.nih.gov/34968454/
4. Li, Qing, Ni, Yong, Zhang, Liren, Tang, Jinhai, Wang, Xuehao. 2021. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. In Signal transduction and targeted therapy, 6, 76. doi:10.1038/s41392-020-00453-8. https://pubmed.ncbi.nlm.nih.gov/33619246/
5. Xia, Haibo, Wu, Yan, Zhao, Jing, Bian, Tao, Liu, Qizhan. 2023. N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2. In Cell death and differentiation, 30, 1293-1304. doi:10.1038/s41418-023-01138-9. https://pubmed.ncbi.nlm.nih.gov/36828914/